Regulation of Pit-1 expression by ghrelin and GHRP-6 through the GH secretagogue receptor
- PMID: 11518797
- DOI: 10.1210/mend.15.9.0694
Regulation of Pit-1 expression by ghrelin and GHRP-6 through the GH secretagogue receptor
Abstract
GH secretagogues are an expanding class of synthetic peptide and nonpeptide molecules that stimulate the pituitary gland to secrete GH through their own specific receptor, the GH-secretagogue receptor. The cloning of the receptor for these nonclassical GH releasing molecules, together with the more recent characterization of an endogenous ligand, named ghrelin, have unambiguously demonstrated the existence of a physiological system that regulates GH secretion. Somatotroph cell-specific expression of the GH gene is dependent on a pituitary-specific transcription factor (Pit-1). This factor is transcribed in a highly restricted manner in the anterior pituitary gland. The present experiments sought to determine whether the synthetic hexapeptide GHRP-6, a reference GH secretagogue compound, as well as an endogenous ligand, ghrelin, regulate pit-1 expression. By a combination of Northern and Western blot analysis we found that GHRP-6 elicits a time- and dose-dependent activation of pit-1 expression in monolayer cultures of infant rat anterior pituitary cells. This effect was blocked by pretreatment with actinomycin D, but not by cycloheximide, suggesting that this action was due to direct transcriptional activation of pit-1. Using an established cell line (HEK293-GHS-R) that overexpresses the GH secretagogue receptor, we showed a marked stimulatory effect of GHRP-6 on the pit-1 -2,500 bp 5'-region driving luciferase expression. We truncated the responsive region to -231 bp, a sequence that contains two CREs, and found that both CREs are needed for GHRP-6-induced transcriptional activation in both HEK293-GHS-R cells and infant rat anterior pituitary primary cultures. The effect was dependent on PKC, MAPK kinase, and PKA activation. Increasing Pit-1 by coexpression of pCMV-pit-1 potentiated the GHRP-6 effect on the pit-1 promoter. Similarly, we showed that the endogenous GH secretagogue receptor ligand ghrelin exerts a similar effect on the pit-1 promoter. These data provide the first evidence that ghrelin, in addition to its previously reported GH-releasing activities, is also capable of regulating pit-1 transcription through the GH secretagogue receptor in the pituitary, thus giving new insights into the physiological role of the GH secretagogue receptor on somatotroph cell differentiation and function.
Similar articles
-
Regulation of the pituitary-specific transcription factor GHF-1/Pit-1 messenger ribonucleic acid levels by growth hormone-secretagogues in rat anterior pituitary cells in monolayer culture.Endocrinology. 1995 Sep;136(9):3863-70. doi: 10.1210/endo.136.9.7649093. Endocrinology. 1995. PMID: 7649093
-
Effect of GHRH and GHRP-2 treatment in vitro on GH secretion and levels of GH, pituitary transcription factor-1, GHRH-receptor, GH-secretagogue-receptor and somatostatin receptor mRNAs in ovine pituitary cells.Eur J Endocrinol. 2004 Feb;150(2):235-42. doi: 10.1530/eje.0.1500235. Eur J Endocrinol. 2004. PMID: 14763922
-
Ghrelin and growth hormone (GH) secretagogues potentiate GH-releasing hormone (GHRH)-induced cyclic adenosine 3',5'-monophosphate production in cells expressing transfected GHRH and GH secretagogue receptors.Endocrinology. 2002 Dec;143(12):4570-82. doi: 10.1210/en.2002-220670. Endocrinology. 2002. PMID: 12446584
-
Clinical pharmacology of human growth hormone and its secretagogues.Curr Drug Targets Immune Endocr Metabol Disord. 2002 Apr;2(1):27-52. Curr Drug Targets Immune Endocr Metabol Disord. 2002. PMID: 12477295 Review.
-
Growth hormone secretagogue actions on the pituitary gland: multiple receptors for multiple ligands?Clin Exp Pharmacol Physiol. 2000 May-Jun;27(5-6):323-9. doi: 10.1046/j.1440-1681.2000.03258.x. Clin Exp Pharmacol Physiol. 2000. PMID: 10831231 Review.
Cited by
-
Pendred syndrome in two Galician families: insights into clinical phenotypes through cellular, genetic, and molecular studies.J Clin Endocrinol Metab. 2008 Jan;93(1):267-77. doi: 10.1210/jc.2007-0539. Epub 2007 Oct 16. J Clin Endocrinol Metab. 2008. PMID: 17940114 Free PMC article.
-
CaMK1D signalling in AgRP neurons promotes ghrelin-mediated food intake.Nat Metab. 2023 Jun;5(6):1045-1058. doi: 10.1038/s42255-023-00814-x. Epub 2023 Jun 5. Nat Metab. 2023. PMID: 37277610
-
Unmasking a new prognostic marker and therapeutic target from the GDNF-RET/PIT1/p14ARF/p53 pathway in acromegaly.EBioMedicine. 2019 May;43:537-552. doi: 10.1016/j.ebiom.2019.04.007. Epub 2019 Apr 8. EBioMedicine. 2019. PMID: 30975543 Free PMC article.
-
Direct inhibition of the DNA-binding activity of POU transcription factors Pit-1 and Brn-3 by selective binding of a phenyl-furan-benzimidazole dication.Nucleic Acids Res. 2008 Jun;36(10):3341-53. doi: 10.1093/nar/gkn208. Epub 2008 Apr 25. Nucleic Acids Res. 2008. PMID: 18440973 Free PMC article.
-
Molecular Mechanisms and Health Benefits of Ghrelin: A Narrative Review.Nutrients. 2022 Oct 8;14(19):4191. doi: 10.3390/nu14194191. Nutrients. 2022. PMID: 36235843 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous